Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor - PubMed (original) (raw)
Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor
J I Jones et al. Proc Natl Acad Sci U S A. 1996.
Abstract
Smooth muscle cells (SMCs) have been shown to migrate in response to insulin-like growth factor I (IGF-I). However, the mechanism mediating this response has not been determined. The migration rates of porcine and human vascular SMCs were assessed in a monolayer wounding assay. IGF-I and IGF-II induced increases of 141% and 97%, respectively, in the number of cells that migrated in 4 days. The presence of 0.2% fetal bovine serum in the culture medium was necessary for the IGFs to stimulate migration over uncoated plastic surfaces. However, if vitronectin was used as the substratum, IGF-I stimulated migration by 162% even in the absence of serum. To determine the role of integrins in mediating this migration, SMC surface proteins were labeled with 125I and immunoprecipitated with specific anti-integrin antibodies. Integrins containing alpha-V (vitronectin receptor), alpha5 (fibronectin receptor), and alpha3 (collagen/laminin receptor) subunits were the most abundant. IGF-I treatment caused a 73% reduction in alpha5-integrin subunit protein and a 25% increase in alpha-V subunit. More importantly, ligand binding of alpha-V-beta3 was increased by 2.4-fold. We therefore examined whether the function of the alpha-V-beta3 integrin was important for IGF-I-mediated migration. The disintegrin kistrin was shown by affinity crosslinking to specifically bind with high affinity to alpha-V-beta3 and not to alpha5-beta1 or other abundant integrins. The related disintegrin echistatin specifically inhibited 125I-labeled kistrin binding to alpha-V-beta3, while a structurally distinct disintegrin, decorsin, had 1000-fold lower affinity. The addition of increasing concentrations of either kistrin or echistatin inhibited IGF-I-induced migration, whereas decorsin had a minimal effect. The potency of these disintegrins in inhibiting IGF-I-induced migration paralleled their apparent affinity for the alpha-V integrin. Furthermore, an alpha-V-beta3 blocking antibody inhibited SMC migration by 80%. In summary, vitronectin receptor activation is a necessary component of IGF-I-mediated stimulation of smooth muscle migration, and alpha-V-beta3 integrin antagonists appear to be important reagents for modulating this process.
Similar articles
- Structural analysis of the role of the beta 3 subunit of the alpha V beta 3 integrin in IGF-I signaling.
Maile LA, Badley-Clarke J, Clemmons DR. Maile LA, et al. J Cell Sci. 2001 Apr;114(Pt 7):1417-25. doi: 10.1242/jcs.114.7.1417. J Cell Sci. 2001. PMID: 11257007 - Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells.
Zheng B, Clemmons DR. Zheng B, et al. Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11217-22. doi: 10.1073/pnas.95.19.11217. Proc Natl Acad Sci U S A. 1998. PMID: 9736716 Free PMC article. - Beta3-integrins rather than beta1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration.
Slepian MJ, Massia SP, Dehdashti B, Fritz A, Whitesell L. Slepian MJ, et al. Circulation. 1998 May 12;97(18):1818-27. doi: 10.1161/01.cir.97.18.1818. Circulation. 1998. PMID: 9603537 - Cell migration: interactions among integrins, IGFs and IGFBPs.
Jones JI, Doerr ME, Clemmons DR. Jones JI, et al. Prog Growth Factor Res. 1995;6(2-4):319-27. doi: 10.1016/0955-2235(95)00015-1. Prog Growth Factor Res. 1995. PMID: 8817675 Review. - Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: cellular responses to changes in multiple signaling inputs.
Clemmons DR, Maile LA. Clemmons DR, et al. Mol Endocrinol. 2005 Jan;19(1):1-11. doi: 10.1210/me.2004-0376. Epub 2004 Nov 4. Mol Endocrinol. 2005. PMID: 15528274 Review.
Cited by
- IGF1R signaling induces epithelial-mesenchymal plasticity via ITGAV in cutaneous carcinoma.
Lopez-Cerda M, Lorenzo-Sanz L, da Silva-Diz V, Llop S, Penin RM, Bermejo JO, de Goeij-de Haas R, Piersma SR, Pham TV, Jimenez CR, Martin-Liberal J, Muñoz P. Lopez-Cerda M, et al. J Exp Clin Cancer Res. 2024 Jul 29;43(1):211. doi: 10.1186/s13046-024-03119-3. J Exp Clin Cancer Res. 2024. PMID: 39075581 Free PMC article. - Inhibition by Thyroid Hormones of Cell Migration Activated by IGF-1 and MCP-1 in THP-1 Monocytes: Focus on Signal Transduction Events Proximal to Integrin αvβ3.
Candelotti E, De Luca R, Megna R, Maiolo M, De Vito P, Gionfra F, Percario ZA, Borgatti M, Gambari R, Davis PJ, Lin HY, Polticelli F, Persichini T, Colasanti M, Affabris E, Pedersen JZ, Incerpi S. Candelotti E, et al. Front Cell Dev Biol. 2021 Apr 8;9:651492. doi: 10.3389/fcell.2021.651492. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33898447 Free PMC article. - Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1.
Takada Y, Takada YK, Fujita M. Takada Y, et al. Cytokine Growth Factor Rev. 2017 Apr;34:67-72. doi: 10.1016/j.cytogfr.2017.01.003. Epub 2017 Feb 3. Cytokine Growth Factor Rev. 2017. PMID: 28190785 Free PMC article. Review. - Branched-chain amino acids regulate insulin-like growth factor-binding protein 1 (IGFBP1) production by decidua and influence trophoblast migration through IGFBP1.
Tanaka K, Sakai K, Matsushima M, Matsuzawa Y, Izawa T, Nagashima T, Furukawa S, Kobayashi Y, Iwashita M. Tanaka K, et al. Mol Hum Reprod. 2016 Aug;22(8):890-9. doi: 10.1093/molehr/gaw032. Epub 2016 May 18. Mol Hum Reprod. 2016. PMID: 27193429 Free PMC article. - Evaluation of Serum Pregnancy Associated Plasma Protein-A & Plasma D-Dimer in Acute Coronary Syndrome.
Nichenametla G, Thomas VS. Nichenametla G, et al. J Clin Diagn Res. 2016 Jan;10(1):BC01-3. doi: 10.7860/JCDR/2016/14432.7011. Epub 2016 Jan 1. J Clin Diagn Res. 2016. PMID: 26894054 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1987 May;84(10):3254-8 - PubMed
- Endocrinology. 1987 Jun;120(6):2251-8 - PubMed
- J Biol Chem. 1989 Dec 25;264(36):21544-9 - PubMed
- Proc Natl Acad Sci U S A. 1990 Apr;87(7):2471-5 - PubMed
- Circ Res. 1990 Jun;66(6):1755-60 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources